Please provide your email address to receive an email when new articles are posted on . A patient should be supine or sitting when an epinephrine autoinjector device is administered per best practice ...
Please provide your email address to receive an email when new articles are posted on . Cases of epinephrine administration for food-induced anaphylaxis in U.S. pediatric EDs increased 4% each year ...
New guidelines help non-medics correctly identify acute allergic reactions requiring epinephrine administration ...
OBJECTIVES: The optimal method for epinephrine administration during neonatal resuscitation is not known. We hypothesized that epinephrine will be delivered more efficiently when administered via a ...
Earlier epinephrine treatment during a cardiac arrest is linked to better recovery compared to later treatment, according to preliminary research to be presented at the American Heart Association's ...
Asphyxia is the most common reason for newborns to fail to make a successful fetal-to-neonatal transition. There is currently a lack of data evaluating hemodynamic effects of epinephrine during ...
The use of epinephrine during cardiac arrest has been advocated for decades and forms an integral part of the published guidelines. Its efficacy is supported by animal data, but human trial evidence ...
WARREN, N.J., July 25, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement ...
Background: Alongside disease progression or neurotoxicity, oxaliplatin-related hypersensitivity reaction is a common reason for treatment discontinuation and remains a critical issue. It is unclear ...
RALEIGH, N.C.--(BUSINESS WIRE)--Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat ...
NORTH HAVEN, Conn., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Insignis Therapeutics, a pharmaceutical company focused on developing innovative allergy and anaphylaxis treatments, is pleased to announce that ...